低分子肝素钙联合复方肾炎片治疗原发性肾病综合征分析  

Therapeutic effect of low molecular weight calciparine combined with Fufang Shenyan pill on primary nephrotic syndrome

作　　者：胡绮雯[1] 刘平[1] 温足珍[1] 

机构地区：[1]南方医科大学附属小榄医院肾内科,广东中山528415

出　　处：《检验医学与临床》2013年第18期2403-2404,共2页Laboratory Medicine and Clinic

摘　　要：目的探究低分子肝素钙联合复方肾炎片治疗原发性肾病综合征的临床疗效。方法将本院2006年9月至2012年9月收治的100例患有原发性肾病综合征患者的临床资料进行回顾性分析,分为实验组和对照组,对照组给予常规治疗,实验组在此基础上给予低分子肝素钙联合复方肾炎片治疗的方法,疗程为1个月。观察治疗后两组治疗有效率、显效率、无效率情况以及血液各生化指标的变化。结果实验组治疗有效率为64.0%明显高于对照组为50.0%,治疗无效也仅有1例,而实验组显效率为34.0%略低于对照组44.0%,具有统计学意义(P<0.05)。而实验组组胆固醇、尿蛋白、三酰甘油、清蛋白在治疗后均较快恢复正常水平,对照组恢复较慢,各指标有部分有较大波动。结论经低分子肝素钙联合复方肾炎片方法治疗临床治愈率较高,值得临床推广使用。Objective To study therapeutic effect of low molecular weight calciparine combined with Fufang Shenyan pill on primary nephrotic syndrome（PNS）.Methods 100patients with PNS,receiving treatment in this hospital from Sep.2006to Sep.2012,were enrolled and divided into control group,receiving routine therapy,and experiment group,receiving combined therapy of low molecular weight calciparine and Fufang Shenyan pill other than routine therapy.One month after therapy,the effective rate,significant efficiency rate,inefficient rate and changes of biochemical indexes were analyzed.Results The effective rate in experiment group was 64.00%,higher than the 50.00%of control group,and the significant efficiency rate was 34.00%,lower than the 44.00%of control group（P0.05）.Levels of cholesterol,urine protein,triglyceride and albumin recovered to normal level more rapidly in experiment group than control group.Conclusion Combined therapy of low molecular weight calciparine and Fufang Shenyan pill could be effective for the therapy of PNS with high clinical cure rate,which might be worthy of clinical promotion.

关 键 词：低分子肝素钙 复方肾炎片 原发性肾病综合征 生化指标 

分 类 号：R692[医药卫生—泌尿科学]